As illustrated in Figure 2B, FLOT2 mRNA was expressed at higher levels in all breast cancer tissues than in adjacent noncancerous tissues, with the differential expression level ranging from 5.1- to 24.4-fold. This evidence concerns the gene FLOT2 and breast carcinoma.